Clinical Trial

Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation

Study acronym: CMV PED
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 6, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational retrospective analysis will provide useful information for clinicians and payers, and local guidelines committee members, to improve the understanding of Cytomegalovirus clinical and economic burden and clinical management of pediatric patients undergoing allogeneic Hematopoietic Stem Cells Transplantation in Italy.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-03-31; most recent amendment 2026-03-31.
Status change: Active, Not Recruiting → Recruiting 2025-07-03
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-06-06
Trial Details
NCT Number NCT06916195
Lead Sponsor MSD Italia S.r.l.
Conditions Cytomegalovirus Infection, Hematopoietic Stem Cells Transplantation
Enrollment 230 participants
Start Date 2025-05-09
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-06